D. E. Shaw & Co., Inc. Medicinova Inc Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.61 - $4.42 $33,530 - $56,783	-12,847 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$3.4 - $4.24 $40,881 - $50,981	-12,024 Reduced 48.35%	12,847 $49,000
Q2 2021 Aug 16, 2021	SELL	$3.76 - $5.14 $29,444 - $40,251	-7,831 Reduced 23.95%	24,871 $106,000
Q1 2021 May 17, 2021	BUY	$4.81 - $8.74 $157,296 - $285,815	32,702 New	32,702 $165,000
Q4 2020 Feb 16, 2021	SELL	$5.03 - $6.31 $52,809 - $66,248	-10,499 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$4.67 - $11.0 $261,599 - $616,187	-56,017 Reduced 84.22%	10,499 $55,000
Q2 2020 Aug 14, 2020	SELL	$3.06 - $7.06 $11,713 - $27,025	-3,828 Reduced 5.44%	66,516 $361,000
Q1 2020 May 15, 2020	SELL	$2.9 - $6.97 $569,905 - $1.37 Million	-196,519 Reduced 73.64%	70,344 $262,000
Q4 2019 Feb 14, 2020	SELL	$6.48 - $8.76 $878,137 - $1.19 Million	-135,515 Reduced 33.68%	266,863 $1.79 Million
Q3 2019 Nov 14, 2019	BUY	$7.7 - $10.42 $39,670 - $53,683	5,152 Added 1.3%	402,378 $3.27 Million
Q2 2019 Aug 14, 2019	BUY	$8.29 - $13.22 $788,760 - $1.26 Million	95,146 Added 31.5%	397,226 $3.81 Million
Q1 2019 May 15, 2019	BUY	$6.82 - $10.27 $243,726 - $367,018	35,737 Added 13.42%	302,080 $2.5 Million
Q4 2018 Feb 14, 2019	BUY	$7.65 - $12.83 $702,361 - $1.18 Million	91,812 Added 52.6%	266,343 $2.18 Million
Q3 2018 Nov 14, 2018	BUY	$7.06 - $12.49 $470,485 - $832,346	66,641 Added 61.77%	174,531 $2.15 Million
Q2 2018 Aug 14, 2018	BUY	$7.96 - $13.23 $580,936 - $965,551	72,982 Added 209.07%	107,890 $850,000
Q1 2018 May 15, 2018	BUY	$6.6 - $13.91 $230,392 - $485,570	34,908 New	34,908 $407,000
Q4 2017 Feb 14, 2018	SELL	$5.89 - $7.21 $73,872 - $90,427	-12,542 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$4.43 - $6.58 $55,561 - $82,526	12,542	12,542 $80,000

Others Institutions Holding MNOV

# of Institutions

Shares Held

4.83M

Call Options Held

9.4K

Put Options Held

View Full List

About MEDICINOVA INC

Ticker MNOV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,046,200
Market Cap $101M
Description
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...

More about MNOV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account